Advanced search
Publication Cover
Journal of Psychoactive Drugs Volume 49, 2017 - Issue 4
Submit an article Journal homepage
1,263
Views
13
CrossRef citations to date
0
Altmetric
Articles

A Physician’s Attempt to Self-Medicate Bipolar Depression with N,N-Dimethyltryptamine (DMT)

Tanida BrownPsychiatry Resident Physician, Banner-University Medical Center, Phoenix, AZ, USACorrespondence[email protected]
, M.D.,
Wanda ShaoPsychiatry Resident Physician, Banner-University Medical Center, Phoenix, AZ, USA;Clinical Associate Instructor, University of Arizona College of Medicine, Phoenix, AZ, USA
, D.O.,
Shehzad AyubAttending Faculty Psychiatrist, Banner-University Medical Center, Phoenix, AZ, USA;Clinical Assistant Professor of Psychiatry, University of Arizona College of Medicine, Phoenix, AZ, USA
, D.O.,
David ChongPsychiatry Resident Physician, Banner-University Medical Center, Phoenix, AZ, USA;Clinical Associate Instructor, University of Arizona College of Medicine, Phoenix, AZ, USA
, M.D. &
Christian CorneliusAttending Faculty Psychiatrist, Banner-University Medical Center, Phoenix, AZ, USA;Clinical Assistant Professor of Psychiatry, University of Arizona College of Medicine, Phoenix, AZ, USA
, M.D.
Pages 294-296 | Received 08 Feb 2017, Accepted 27 Mar 2017, Published online: 07 Jul 2017

References

  • Balon, R. 2007. Psychiatrist attitudes toward self-treatment of their own depression. Psychotherapy and Psychosomatics 76:306–10. doi:10.1159/000104707.
  • de Lima Osório, F., L. de Macedo, J. de Sousa, J. Pinto, J. Quevedo, J. Crippa, and J. Hallak. 2011. The therapeutic potential of harmine and ayahuasca in depression: Evidence from exploratory animal and human studies. In The ethnopharmacology of ayahuasca, edited by R. G. dos Santos, 75–85. Trivandrum, India: Transworld Research Network.
  • de Lima Osório, F., R. Saches, L. Macedo, R. dos Santos, J. Oliveira, D. de Araujo, J. Riba, J. Crippa, and J. Hallak. 2015. Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: A preliminary report. Revista Brasileira de Psiquiatria 37:13–20. doi:10.1590/1516-4446-2014-1496.
  • Domínguez-Clavé, E., J. Soler, M. Elices, J. Pascual, E. Alvarez, M. de la Fuente Revenga, P. Friedlander, A. Feilding, and J. Riba. 2016. Ayahuasca: Pharmacology, neuroscience and therapeutic potential. Brain Research Bulletin: Neurobiology of Emerging Psychoactive Drugs 126:89–101. doi:10.1016/j.brainresbull.2016.03.002.
  • dos Santos, R., J. Bouso, and J. Hallak. 2017. Ayahuasca dimethyltryptamine, and psychosis: A systematic review of human studies. Therapeutic Advances in Psychopharmacology 7:141–157.
  • dos Santos, R., F. Osório, J. Crippa, and J. Hallak. 2016. Antidepressive and anxiolytic effects of ayahuasca: A systemic literature review of animal and human studies. Revista Brasileira de Psiquiatria 38:65–72. doi:10.1590/1516-4446-2015-1701.
  • Erowid. 2015. Erowid DMT vault: Dosage. Erowid.com. https://erowid.org/chemicals/dmt/dmt_dose.shtml ( accessed March 13, 2017).
  • Gonazalez-Maeso, J., and S. Sealfon. 2009. Agonist-trafficking and hallucinogens. Current Medicinal Chemistry 16:1017–27. doi:10.2174/092986709787581851.
  • Jiang, X., H. Shen, D. Mager, and A. Yu. 2013. Pharmacokinetic interactions between monoamine oxidase A inhibitor harmaline and 5-methoxy-N,N-dimethyltryptamine, and the impact of CYP2D6 status. Drug Metabolism and Disposition 41:975–86. doi:10.1124/dmd.112.050724.
  • Liester, M., and J. Prickett. 2012. Hypotheses regarding the mechanisms of ayahuasca in the treatment of addictions. Journal of Psychoactive Drugs 44:200–08. doi:10.1080/02791072.2012.704590.
  • Palhano-Fontes, F., J. Alchieri, J. Oliveira, B. Soares, J. Hallak, N. Galvao-Coelho, and D. de Araujo. 2014. The therapeutic potentials of ayahuasca in the treatment of depression. In The therapeutic use of ayahuasca, edited by B. Labate and C. Cavnar, 23–39. Berlin, Germany: Springer.
  • Riba, J., E. McIlhenny, M. Valle, J. Bouso, and S. Barker. 2012. Metabolism and disposition of N,N-dimethyltryptamine and harmala alkaloids after oral administration of ayahuasca. Drug Testing and Analysis 4:610–16. doi:10.1002/dta.1344.
  • Riba, J., E. H. McIlhenny, J. C. Bouso, and S. Barker. 2015. Metabolism and urinary disposition of N,N-dimethyltryptamine after oral and smoked administration: A comparative study. Drug Testing and Analysis 7:401–06. doi:10.1002/dta.v7.5.
  • Sanches, R., F. de Lima Osório, R. dos Santos, L. Macedo, J. Oliveira, L. Ana, J. Crippa, and J. Hallak. 2016. Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: A SPECT study. Journal of Clinical Psychopharmacology 36:77–81. doi:10.1097/JCP.0000000000000436.
  • Straussman, R. 2000. DMT: The spirit molecule: A doctor’s revolutionary research into the biology of near-death and mystical experiences. Rochester, VT: Park Street Press.
  • Szmulewicz, A., M. Valerio, and J. Smith. 2015. Switch to mania after ayahausca consumption in a man with bipolar disorder: A case report. International Journal of Bipolar Disorder 24:4. doi:10.1186/s40345-014-0020-y.
  • Valle, M., A. Magueda, M. Rabella, A. Rodriguez-Pujadas, R. Antonijoan, S. Romero, J. Alonso, M. Mananas, S. Barker, P. Friedlander, A. Feilding, and J. Riba. 2016. Inhibition of alpha oscillations through serotonin-2A receptor activation underlines the visual effects of ayahuasca in humans. European Neuropsychopharmacology 26:1161–75. doi:10.1016/j.euroneuro.2016.03.012.
  • Van den Buuse, M., E. Ruimschotel, S. Martin, V. Risbrough, and A. Halberstadt. 2011. Enhanced effects of amphetamine but reduced effects of hallucinogen, 5-MeO-DMT, on locomotor activity in 5-HT(1A) receptor knockout mice: Implications for schizophrenia. Neuropharmacology 61:209–16. doi:10.1016/j.neuropharm.2011.04.001.
  • Winstock, A., S. Kaar, and R. Borschmann. 2014. Dimethyltryptamine (DMT): Prevalence, user characteristics and abuse liability in a large global sample. Journal of Psychopharmacology 28:49–54. doi:10.1177/0269881113513852.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.